1. Overview of the lipid formulations of amphotericin B;Dupont;J Antimicrob Chemother,2002
2. Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosis;Mouton;Med Mycol,2009
3. Post-marketing study to assess the safety, tolerability and effectiveness of Fungisome: an Indian liposomal amphotericin B preparation;Sanath;J Postgrad Med,2005
4. Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection;Bodhe;J Assoc Physicians India,2002
5. Preclinical & pharmaceutical testing of liposomal amphotericin B;Gokhale;Indian J Med Res,1993